Skip to main content

Table 2 Overview CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

  MD Controls p value
N = 63 N = 26
LV-EDVi, ml/m2 85 ± 30 86 ± 16 0.80
LV-ESVi, ml/m2 41 ± 21 31 ± 9 0.003
LV-massi, g/m2 60 ± 16 58 ± 10 0.69
LV-EF, % 53 ± 12 64 ± 6 <0.0001
RV-EF, % 53 ± 9 55 ± 8 0.47
LV-EF <55 %, n (%) 29 (46) 0 (0) <0.0001
RV-EF <45 %, n (%) 10 (16) 0 (0) 0.031
LGE presence, n (%) 48 (76) 0 (0) <0.0001
LGE extent, % 7 (1-17) - -
Abnormal CMR, n (%) 49 (78) 0 (0) <0.0001
  1. Bold text indicates a significant p-value of <0.05